Implantable device comprising a substrate pre-coated with stabilized fibrin

Patent metadata

Field	Value
Publication number	US-10039865-B2
Application number	US-56366709-A
Country	US
Kind code	B2
Filing date	Sep 21, 2009
Priority date	Sep 22, 2008
Publication date	Aug 7, 2018
Grant date	Aug 7, 2018

Abstract

The invention relates to a prosthetic for repairing an opening or a defect in a soft tissue, to its preparation and use. The prosthetic of the invention comprises a substrate viscerally-coated with stabilized and non-completely dry fibrin. The prosthetic displays reduced postoperative complications following its implantation.

First claim

What is claimed is:

1. A method for producing an improved implantable mesh for repairing an opening or a defect in a soft tissue, the mesh having a visceral and a non-visceral surface, and the visceral surface is the portion of the surface which faces away from the fascia defect and allows reduction of postoperative adhesions, the method comprising the steps of: applying at room temperature to a visceral surface of a mesh a defined volume of an aqueous solution comprising fibrinogen and an aqueous solution comprising a proteolytic enzyme that reacts with fibrinogen to convert the fibrinogen into a homogeneously distributed fibrin coating on the visceral surface, adding a solute capable of binding free water and having a molecular weight of about 1,000 Dalton or less; and drying the fibrin coating,
thereby obtaining a ready to use implantable mesh comprising a stabilized dry and homogenous fibrin coating on the visceral surface for placing the non-visceral surface of the mesh facing the opening or defect and for placing the visceral surface facing away from the opening or defect for reducing postoperative adhesions.

2. The method according to claim 1 , wherein the surface of the substrate is activated prior to forming the fibrin coating such as by plasma treatment.

3. The method according to claim 1 , wherein said proteolytic enzyme is thrombin.

4. The method according to claim 1 , wherein said opening or defect is a hernia.

5. The method according to claim 1 , wherein a solute is added prior to the drying step, and wherein the concentration of said solute in the fibrin coating following the drying step is in the range of about 5%-68%, in the range of about 20%-68%, in the range of about 20%-32%, or in the range of about 51%-68%.

6. The method according to claim 1 , wherein said drying is carried out by non-intensive drying.

7. The method according to claim 1 , wherein the temperature during the drying step is less than 37° C.

8. The method according to claim 1 , wherein after the drying step said fibrin coating comprises a residual water content of about 3% to about 20%.

9. The method according to claim 6 , wherein the non-intensive drying is by air drying.

Assignees

• Sheetrit Eyal
• Nur Israel
• Bar Liliana
• Weissman Lior
• Omrix Biopharmaceuticals Ltd

Inventors

• Sheetrit Eyal
• Nur Israel
• Bar Liliana
• Weissman Lior

Classifications

• A61L31/143 Primary

  Stabilizers · CPC title

• A61L31/10

  Macromolecular materials · CPC title

• C08L89/00

  Compositions of proteins; Compositions of derivatives thereof (foodstuff preparations A23J3/00) · CPC title